UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000012433
Receipt number R000014526
Scientific Title Open-label clinical trial to evaluate the safety and efficacy of the investigational devices in total hip arthroplasty.
Date of disclosure of the study information 2013/12/01
Last modified on 2015/06/12 16:22:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Open-label clinical trial to evaluate the safety and efficacy of the investigational devices in total hip arthroplasty.

Acronym

Open-label clinical trial to evaluate the safety and efficacy of the investigational devices in total hip arthroplasty.

Scientific Title

Open-label clinical trial to evaluate the safety and efficacy of the investigational devices in total hip arthroplasty.

Scientific Title:Acronym

Open-label clinical trial to evaluate the safety and efficacy of the investigational devices in total hip arthroplasty.

Region

Japan


Condition

Condition

Patients with hip joint disease caused by hip osteoarthritis and others.

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We confirm the functional equivalency of the investigational devices to the approved artificial hip joint as well as absence of serious adverse device effects in clinical trial.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Japanese orthopedic association hip score
Serious adverse device effect

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

-

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Patients with an indication for THA who are selected by orthopedic specialist of the JOA and consented to the operation.
2) Inpatients or outpatients with a written first-person consent.
3) Patients aged 20 and over.
(Not gender specific)

Key exclusion criteria

The exclusion criteria having effects on the evaluation of the investigational devices.
1) Patients who had or will have THA or BHA in the opposite hip within 6 months before or after the operation in this clinical trial.
2) Patients who previously had THA or BHA in the opposite hip and it is apparent that prosthesis exhibits loosening.
3) Patients who are difficult to be followed for 6 months after the surgery.
4) Patients who participated clinical trial of another investigational device or drug within 6 months before participating to this clinical trial.
5) Patients who once participated this clinical trial.
6) Patients in unstable clinical conditions or fatal condition.
7) Patients who have clinically serious organ derangement.

*Additionally, there are exclusion criteria related to the product characteristics of the investigational devices.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroko Tanioka

Organization

KYOCERA Medical Corporation

Division name

Regulatory Affairs Development Dept. Research and Development Corporate Division

Zip code


Address

3-3-31 Miyahara, Yodogawa-Ku, Osaka, 532-0003 Japan

TEL

06-6350-1493

Email

hiroko.tanioka@kyocera-md.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kiyoyasu fujii

Organization

KYOCERA Medical Corporation

Division name

Regulatory Affairs Development Dept. Research and Development Corporate Division

Zip code


Address

3-3-31 Miyahara, Yodogawa-Ku, Osaka, 532-0003 Japan

TEL

06-6350-1493

Homepage URL


Email

kiyoyasu.fujii@kyocera-md.jp


Sponsor or person

Institute

KYOCERA Medical Corporation

Institute

Department

Personal name



Funding Source

Organization

KYOCERA Medical Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

佐賀大学医学部附属病院(佐賀県)


Other administrative information

Date of disclosure of the study information

2013 Year 12 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 09 Month 12 Day

Date of IRB


Anticipated trial start date

2013 Year 12 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2013 Year 11 Month 28 Day

Last modified on

2015 Year 06 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014526


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name